Empirical Wealth Management’s Opus Genetics IRD Stock Holding History

Empirical Wealth Management’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$95.1K	Buy	+19,649	New	+$81.6K	﹤0.01%	1130

Other funds holding IRD

Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return

James Investment Research Alpha, Ohio $936M AUM 24.49% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

First City Capital Management Savannah, Georgia $204M AUM 20.28% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Hilton Head Capital Partners Hilton Head Island, South Carolina $185M AUM 26.97% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Empirical Wealth Management's IRD Position: Q3 2026 in Review

Empirical Wealth Management opened a new position in Opus Genetics (IRD) in Q3 2026: 19,649 shares worth $95.1K. The stake represents ﹤0.01% of the portfolio and ranks #1130 among its holdings.

14 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

Empirical Wealth Management held 19,649 shares of Opus Genetics worth $95.1K as of Q3 2026.
Opus Genetics was a new Empirical Wealth Management position in Q3 2026.
Opus Genetics made up ﹤0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #1130 holding.
14 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.